Latest Breaking News On - Josephine belluardo - Page 1 : comparemela.com

First Patient Treated in Alpha-1 Antitrypsin Deficiency Liver Disease Phase 3 Study Triggering $40 Million Milestone Payment from Takeda to Arrowhead

First Patient Treated in Alpha-1 Antitrypsin Deficiency Liver Disease Phase 3 Study Triggering $40 Million Milestone Payment from Takeda to Arrowhead
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United-states
Brian-ritchie
Vince-anzalone
Josephine-belluardo
Exchange-commission
Drug-administration
Arrowhead-pharmaceuticals
Nasdaq
Lifesci-communications
Lifesci-advisors
Arrowhead-pharmaceuticals-inc
Wall-street

Arrowhead Pharmaceuticals Announces $30 Million Milestone Payment from GSK

Arrowhead Pharmaceuticals Announces $30 Million Milestone Payment from GSK
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

China
Josephine-belluardo
Vince-anzalone
Brian-ritchie
Arrowhead-pharmaceuticals
Lifesci-communications
Nasdaq
Exchange-commission
Arrowhead-pharmaceuticals-inc
Lifesci-advisors
Greater-china
Harbor-statement

Arrowhead Pharmaceuticals Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

Arrowhead Pharmaceuticals Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Brian-ritchie
Josephine-belluardo
Vince-anzalone
Exchange-commission
Nasdaq
Arrowhead-pharmaceuticals-inc
Arrowhead-pharmaceuticals
Lifesci-advisors
Lifesci-communications
Compensation-committee
Harbor-statement
Private-securities-litigation-reform-act

Arrowhead Pharmaceuticals Inc. (ARWR) Reports Interim Results from Ongoing Phase 1/2 Study of ARO-C3

Arrowhead Pharmaceuticals Inc. (ARWR) Reports Interim Results from Ongoing Phase 1/2 Study of ARO-C3
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Josephine-belluardo
Vince-anzalone
James-hamilton
Brian-ritchie
Exchange-commission
Arrowhead-pharmaceuticals
Lifesci-advisors
Lifesci-communications
Arrowhead-pharmaceuticals-inc
Nasdaq
Wall-street
Harbor-statement

Takeda (TAK) and Arrowhead (ARWR) Report Topline Results from SEQUOIA Phase 2 Study of Fazirsiran

Takeda (TAK) and Arrowhead (ARWR) Report Topline Results from SEQUOIA Phase 2 Study of Fazirsiran
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United-states
Japan
United-kingdom
London
City-of
Japanese
Chinwe-ukomadu
Josephine-belluardo
Yuko-yoneyama
Vince-anzalone
Chris-stamm
Brian-ritchie